anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Callout

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 96,741
Current window 75,061-75,090
Pages 3,225
Rows per page 30
Component: Calloutclear collectionreset all
18 30 60

Component

75,061-75,090 of 96,741

filter-aware
166
The slide uses direct quotes from KOLs and former executives to undermine the credibility of Nevro's clinical trials.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
167
Uses multiple KOL quotes to undermine the company's growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
168
The slide uses direct quotes from KOLs to undermine the company's technical claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
169
Uses expert testimony (KOLs and former executives) to undermine the company's growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
170
The slide uses a 'quote-sandwich' structure to validate the thesis headline.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
171
Uses expert testimony to contradict company growth narratives.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
172
Uses a direct quote from a KOL to undermine the company's growth thesis.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
173
Uses expert testimonials to debunk company growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
174
Features highlighted text blocks in yellow to emphasize critical quotes from former executives.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
175
Uses expert testimony to frame the company's situation as dire.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
176
Uses expert testimony to undermine management credibility and highlight operational failures.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
177
The slide uses expert testimony to undermine the credibility of the CEO and the company's strategic direction.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
178
Uses expert testimony to undermine the investment thesis of a turnaround.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
179
The slide uses expert testimony to undermine the credibility of the CEO and the company's growth prospects.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
180
Uses expert consultation quotes to undermine the credibility of the CEO's turnaround narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
181
The slide uses a direct quote from a 'Longtime C-level executive' to undermine investor confidence in the CEO.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
182
The slide uses a testimonial to debunk the 'take-out' thesis, framing the company as a 'one-trick pony' in a 'price war'.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
183
Uses expert testimony to debunk market optimism regarding M&A.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
184
The slide uses expert testimony to debunk the bull case of a potential acquisition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
185
The slide uses direct quotes from industry experts to undermine the investment thesis of Nevro, specifically targeting the idea of a potential acquisition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
186
The slide uses a 'villain' framing by characterizing Nevro's technology as 'gimmicky' and 'one-size fits all' while highlighting a competitor's superior clinical outcomes.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
187
Uses OpenPayments data to link Nevro's top paid KOLs to the Saluda clinical trial authorship.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
188
The slide uses expert quotes to build a narrative of competitive vulnerability for Nevro.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
189
The slide uses highlighted text to emphasize key negative sentiment regarding Nevro's customer loyalty and future market position.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
190
The slide uses a 'villain critique' style by highlighting the defection of key opinion leaders (KOLs) from the subject company to a competitor.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
191
The slide uses quotes from industry experts to allege unethical behavior and kickbacks in the neuromodulation market.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
192
Includes a direct testimonial quote highlighted in yellow.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
193
Uses quotes from industry participants to validate the thesis of unsustainable pricing pressure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
194
The slide uses expert testimony to contradict potential growth narratives, specifically highlighting a $5,000 price erosion per device.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
195
Uses expert testimony to frame the company's pricing strategy as a terminal failure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit